跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DAPA-TABS indapamide hemihydrate 2.5 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
DAPA-TABS indapamide hemihydrate 2.5 mg tablet blister pack
Approved
STANDARD
DAPA-TABS indapamide hemihydrate 2.5 mg tablet blister pack
Alphapharm Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
cad3c5772abf1a46
Company
Alphapharm Pty Ltd
Type
Standard
Approval Details
Approval Id
cad3c5772abf1a46
Product Name
DAPA-TABS indapamide hemihydrate 2.5 mg tablet blister pack
Artg Id
62367
Artg Name
DAPA-TABS indapamide hemihydrate 2.5 mg tablet blister pack
Sponsor
Alphapharm Pty Ltd
Company Detail Path
/organization/alphapharm-pty-ltd
Artg Date
1997-11-21
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/cbbd39796e8d720b6236884afe2ce943.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/a69cdb40665c80371aea38763436d166.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
cad3c5772abf1a46
Type
Standard
Back to TGA Approvals